This contract involves the delivery of fibrinogen concentrate to ensure continuous treatment for patients suffering from fibrinogen deficiency, a crucial blood clotting factor. The concentrate will be supplied to designated Regional Blood Donation and Transfusion Centers (RCKiK) as specified by the
Contract awarded. Originally published 1 years ago.
No single supplier dominates the field.
In healthcare medical, NATIONAL BLOOD CENTER has awarded 3 contracts to 3 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the delivery of fibrinogen concentrate to ensure continuous treatment for patients suffering from fibrinogen deficiency, which is a blood clotting factor. The concentrate will be supplied to designated recipients, specifically the Regional Blood Donation and Blood Treatment Ce
This contract involves the production and delivery of promotional materials aimed at healthcare entities and diagnostic laboratories as part of educational initiatives. The required printed materials include: 510 posters, 18,900 patient leaflets, 5,200 staff leaflets, and 1,260 informational badges/
This contract involves the delivery of Prothrombin Complex Concentrate (PCC) to ensure continuous treatment for patients with prothrombin complex factor deficiencies. The PCC, classified as a prescription medication, will be supplied to designated recipients, specifically the Regional Blood Donation
This contract involves the delivery of human coagulation factor VIII concentrate containing von Willebrand factor. The purpose is to ensure continuous treatment for patients with von Willebrand disease, with a required ratio of at least 1 unit of von Willebrand factor to 1 unit of factor VIII. Suppl
UK Home Office seeks a global tuberculosis screening service provider to manage visa applicant testing across international locations through various delivery models.
Norfolk County Council is seeking a contractor to provide technology-enabled and virtual care services that help residents maintain independence and improve outcomes while remaining in their own homes.
Market engagement RFI for integrated criminal justice liaison, prison reentry and mental health treatment services across Lancashire and Cumbria, closing 4 September 2026.
UKHSA is seeking supplier participation in a market engagement exercise for Pralidoxime Chloride supply in 2026 through a formal Request for Information process.
